Centene Reports $6.6 Billion Quarterly Loss Amid Rising Costs and Medicaid Cuts

Health insurer absorbs $6.7B goodwill impairment as Trump’s “One Big Beautiful Bill” reshapes Medicaid funding

Health insurance giant Centene Corporation (NYSE: CNC) reported a staggering $6.6 billion third-quarter loss, weighed down by escalating healthcare costs and a massive non-cash goodwill impairment tied to stock declines and sweeping U.S. healthcare policy changes.

The loss, disclosed in Centene’s third-quarter results Wednesday, contrasts sharply with $713 million in profit reported during the same period last year. The company’s GAAP diluted loss per share was $(13.50), while adjusted earnings per share came in at $0.50, reflecting an improved adjusted outlook and stronger operational performance in select business segments.

$6.7 Billion Impairment Linked to Medicaid Cuts and Market Weakness

Centene said it recorded a $6.7 billion goodwill impairment after completing a third-quarter valuation review, citing two key factors a sustained decline in its stock price throughout 2025 and the expected financial impact of President Trump’s recently enacted “One Big Beautiful Bill”, which includes $1 trillion in cuts to Medicaid and Affordable Care Act subsidies over the next decade.

The legislation is projected by the Congressional Budget Office to eliminate health coverage for nearly 12 million Americans, intensifying the challenge for insurers like Centene that manage Medicaid plans for more than 12 million low-income members nationwide.

Analysts warn that heightened “redeterminations” — eligibility checks designed to remove ineligible Medicaid enrollees — could accelerate membership losses. These bureaucratic hurdles have already resulted in millions of people losing Medicaid coverage since pandemic-era protections expired in 2023.

“As a result of market conditions in July 2025, including the One Big Beautiful Bill Act and the decline in the company’s stock price, we performed a quantitative impairment analysis,” Centene said in its filing.

Rising Healthcare Costs Squeeze Margins

Despite higher revenues, the company’s profitability was hit hard by surging medical costs across Medicaid, Medicare, and ACA Marketplace plans.

Centene’s health benefits ratio (HBR) — the percentage of premiums spent on medical care — rose to 92.7%, up from 89.2% a year ago. The increase was driven by:

• Higher Marketplace medical costs and lower risk adjustment revenue,
• Prescription drug plan changes tied to the Inflation Reduction Act, and
• Rising behavioral and home health costs within Medicaid programs.

The company said these pressures were “partially offset by Medicaid rate increases,” but admitted they contributed to a weaker-than-expected margin environment across several states.

Solid Revenue and Cash Flow Despite Policy Headwinds

Total revenues climbed 22% year-over-year to $49.7 billion, including $44.9 billion in premium and service revenue. Growth was led by:

• A 9% increase in Medicaid revenue to $23.2 billion,
• A 26% surge in Marketplace (commercial) revenue to $11.0 billion, and
• A 66% jump in Medicare-related revenue to $9.4 billion, reflecting expansion in prescription drug plans.

Centene also reported $1.4 billion in operating cash flow, aided by the timing of claims payments, and maintained $38.8 billion in cash and investments with a 45.5% debt-to-capital ratio at quarter-end.

Membership across all lines totaled 27.9 million, slightly down from 28.6 million a year earlier, due mainly to attrition in Medicaid enrollment partially offset by Marketplace and PDP (prescription drug plan) growth.

Full-Year Guidance Raised Despite $6.6B Loss

Even amid heavy impairment charges, Centene raised its full-year adjusted EPS forecast by $0.25 to at least $2.00, signaling confidence in its turnaround efforts. The company also expects its GAAP diluted loss per share to be no greater than $(12.85) for 2025.

“Our third quarter results and increased full-year outlook demonstrate tangible progress against the milestones we laid out in July,” said CEO Sarah M. London. “While much work remains ahead, we are focused on improving margins, delivering strong outcomes for members, and positioning Centene for long-term success.”

Community Investment and Recognition

Despite financial challenges, Centene continued investing in community initiatives through its foundation and subsidiaries:

• Opened a new community health center in Uvalde, Texas, offering primary care, behavioral health, and workforce training.
• Launched youth mental health programs in Indiana and clinician well-being initiatives in North Carolina.
• Named among Forbes’ inaugural “Best Employers for Company Culture” list in September.

Outlook: Navigating Policy and Cost Uncertainty

Looking forward, Centene faces a complex environment shaped by rising medical inflation, new Medicaid regulations, and political uncertainty surrounding healthcare funding. The company’s strategy centers on tight cost control, digital transformation, and contract renegotiations to preserve margins.

While the goodwill impairment is non-cash, it underscores investor unease about the long-term implications of federal budget cuts and pricing volatility in government-subsidized health programs.

Still, Centene’s leadership remains optimistic: its large membership base, diversified portfolio, and stable cash position give it flexibility to adapt — even as Washington’s shifting policies redefine the future of U.S. healthcare coverage.